SCHEMBL7676544

SCHEMBL7676544

COc1cc(C2(O)CCN(C(=O)OCc3ccccc3)CC2)ccc1SC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 1/20 0.49
SCN5A Q14524 1/20 0.45
SCN9A Q15858 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CCR1 P32246 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
CHRM4 P08173 1/20 0.43
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
PTGDR2 Q9Y5Y4 4/20 0.42
PDE4B Q07343 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.41
ENPP2 Q13822 1/20 0.41
ATXN2 Q99700 1/20 0.41
KDM1A O60341 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608659 0.83 SCN5A (0.52) NOS2SCN5ASCN9AMEN1KMT2A
SCHEMBL8316039 0.82 CCR1 (0.51) NOS2MEN1KMT2ANPSR1CCR1
SCHEMBL8315425 0.81 OPRD1 (0.54) NOS2SCN5ASCN9AMEN1KMT2A
SCHEMBL7504527 0.80 ALDH1A1 (0.60) NOS2SCN5ASCN9AMEN1KMT2A
SCHEMBL6604538 0.80 SCN5A (0.51) NOS2SCN5ASCN9AMEN1KMT2A
SCHEMBL6611044 0.80 MEN1 (0.50) NOS2SCN5ASCN9AMEN1KMT2A
SCHEMBL7556949 0.79 CHRM4 (0.61) NOS2MEN1KMT2ANPSR1CCR1
SCHEMBL7672654 0.79 PDE4B (0.63) MEN1KMT2ANPSR1SMN1; SMN2NPC1
SCHEMBL7501537 0.79 APP (0.55) NOS2SCN5ASCN9AMEN1KMT2A
SCHEMBL29995634 0.78 NOS2 (0.54) NOS2MEN1KMT2ANPSR1CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365602-B1 FOR THERAPY OF DEPRESSION, ANXIETY, ASTHMA, PAIN, INFLAMMATION, URINARY INCONTINENCE AND OTHER DISEASE CONDITIONS ASTRA ZENECA AB (SE) 2002-04-02 US disclosed
EP-1097137-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-05-09 EP disclosed
WO-2000002859-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed